Report : North America Carboxy Therapy Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Type (Tabletop, Portable, and Others), Application [Aesthetic Medicine (Cellulite, Stretch Marks, Alopecia, and Dark Under-Eye Circles, Dermatology, Gynecology, Angiology, Orthopedics & Rheumatology, Sports Medicine, and Others], and End User (Hospitals, Aesthetic Clinics, and Wellness Center)
At 12.2% CAGR, the North America Carboxy Therapy Market is speculated to be worth US$ 72.69 million by 2028, says Business Market Insights
According to the Insight Partners’ research, the North America carboxy therapy market was valued at US$ 36.35 million in 2022 and is expected to reach US$ 72.69 million by 2028, registering a CAGR of 12.2% from 2022 to 2028. Growing uptake of non-invasive aesthetic procedures and increasing demand for anti-aging treatments along with surge in geriatric population are the critical factors attributed to the North America carboxy therapy market expansion.
The World Health Organization (WHO) recognizes waste reduction in healthcare delivery as an essential aspect of strengthening healthcare systems. Technological advancements have led to the development of surgical approaches that minimize waste and achieve better results with available resources. Minimally invasive surgeries (MIS) and non-invasive procedures are among the approaches that result in low waste generation and reduced medical expenses. Moreover, these procedures ensure low absenteeism at the workplace, which has a net positive effect on the productivity of an economy. Minimal invasiveness results in faster recovery, lesser scarring, limited stress, and better patient satisfaction. The modern concept of natural and harmonious rejuvenation is based on a comprehensive, three-dimensional, multi-layered approach that combines several active ingredients and techniques in procedures, such as skin relaxation, surface renewal, and skin tightening, depending on the specific patient’s needs. Since the appearance of the skin is considered an essential factor in wellbeing and health, the number of aesthetic procedures performed is increasing steadily. Further, nonsurgical procedures include facial injections, which help correct facial lines, wrinkles, cellulite reduction, and unwanted fat reduction with minimal side effects. The International Society of Aesthetic Plastic Surgery (ISAPS) defines a nonsurgical cosmetic procedure as an effective and safe procedure for those who are willing to undergo subtle enhancement and surgical result enhancement with lower recovery periods; these procedures often do not require extensive training, unlike surgical procedures that are associated with greater risks. Thus, the surge in the uptake of minimally invasive and noninvasive aesthetic procedures is driving the North America carboxy therapy market.
On the contrary, regulatory policies and safety concerns associated with carbon therapy hurdles the growth of North America carboxy therapy market.
Based on type, the North America carboxy therapy market is segmented into tabletop, portable, and others. The tabletop segment held 47.2% share of North America carboxy therapy market in 2022, amassing US$ 17.15 million. It is projected to garner US$ 34.14 million by 2028 to expand at 12.2% CAGR during 2022–2028.
Based on application, the North America carboxy therapy market is segmented into aesthetic medicine, dermatology, angiology, gynecology, orthopedics and rehumatology, sports medicine, and others. The aesthetic medicine segment held 55.1% share of North America carboxy therapy market in 2022, amassing US$ 20.04 million. It is projected to garner US$ 39.99 million by 2028 to expand at 12.2% CAGR during 2022–2028. The aesthetic medicine segment is further sub segmented into cellulite, stretch marks, alopecia, and dark under-eye circles.
Based on end user, the North America carboxy therapy market is segmented into hospitals, aesthetic clinics, and wellness center. The hospitals segment held 49.1% share of North America carboxy therapy market in 2022, amassing US$ 17.85 million. It is projected to garner US$ 35.56 million by 2028 to expand at 12.2% CAGR during 2022–2028
Based on country, the North America carboxy therapy market has been categorized into the US, Canada, and Mexico. Our regional analysis states that the US captured 90.7% share of North America carboxy therapy market in 2022. It was assessed at US$ 32.98 million in 2022 and is likely to hit US$ 65.89 million by 2028, exhibiting a CAGR of 12.2% during the forecast period.
Key players profiles in the North America carboxy therapy market report are Carbossiterapia Italiana; DTA Medical; Kastner-Praxisbedarf; MBE Medical Division; Mezopharma; and Nick Fanavaran Plasma Company, among others.
Contact Person: Sameer Joshi
Phone: +1- 646- 491- 9876
Email id: firstname.lastname@example.org